Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

IO Partnering Strategies In an Increasingly Complex Environment

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11312263
archived

In this panel, moderated by Dr Axel Hoos, GSK, individuals from large pharma and biotech business development leads discuss decision-making when it comes to partnering and collaborations in today’s IO environment.

  • What is the current nature and types of partnerships being done in IO?
  • Is dealmaking and partnerships evolving due to the need for IO combinations? How so?
  • What is the balance between in house R&D and external innovation in IO?
  • What is the decision making regarding exclusive licensing and “no strings attached” partnerships?

Save the date for IO Combinations 360° happening June 20-21, 2019 at the Wyndham Historic District Hotel, Philadelphia, PA and for IO360° happening February 26-28, 2020 at the Crowne Plaza Times Square in New York City. 

Comments